Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...

Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.

It is often assumed that any material that lowers the surface tension of water in the spray mixture or increases the wetability of the spray solution on plant leaf surfaces is an adequate adjuvant.

The Adjuvant! Online software was used to divide the same population into high-risk (n = 152) and low-risk (n = 46) groups on the basis of clinical factors. Among patients classified as low risk ...

Updated results from the KATHERINE trial showed that adjuvant T-DM1 provided a significant improvement in overall survival and no evidence of long-term safety issues.